Renee Ryan is recognized as an industry insider and leading investor, deal-maker, and innovator. She will present Cala Health at the 2021 Emerging Medtech Summit.
Ryan has 25 years of building category-creating healthcare companies. She led the medical technology investments for Johnson & Johnson Innovation (JJDC) on the West Coast and Asia Pacific for 8 years. While at J&J, she made over 15 new investments, including the Series A for Cala Health. Previously, she was a healthcare investment banker at RW Baird, Jefferies and Goldman Sachs
CEO, Founder, and proud member and connector in the Medtech ecosystem. As CEO of LSI, a global healthcare market research and advisory firm, I support startups, investors, strategics, and professional service companies by providing independent market data/insights to help inform their decisions. I aim to leverage my deep network to connect investors with innovators tackling the world's biggest healthcare challenges. Proud to be the Founder of the US and European Emerging Medtech Summit events which have become the go-to investment & partnering conferences in Medtech. I've managed over 200 consulting and due diligence engagements with companies such as J&J, Medtronic, Abbott, Siemens Healthineers, General Electric, amongst others. Proud and honored to serve as a Board Advisor to several early/growth-stage companies and to advise private investors, family offices, PE firms, and SPACs to identify new opportunities in healthcare.
CEO, Founder, and proud member and connector in the Medtech ecosystem. As CEO of LSI, a global healthcare market research and advisory firm, I support startups, investors, strategics, and professional service companies by providing independent market data/insights to help inform their decisions. I aim to leverage my deep network to connect investors with innovators tackling the world's biggest healthcare challenges. Proud to be the Founder of the US and European Emerging Medtech Summit events which have become the go-to investment & partnering conferences in Medtech. I've managed over 200 consulting and due diligence engagements with companies such as J&J, Medtronic, Abbott, Siemens Healthineers, General Electric, amongst others. Proud and honored to serve as a Board Advisor to several early/growth-stage companies and to advise private investors, family offices, PE firms, and SPACs to identify new opportunities in healthcare.
Passionate supporter of innovation and entrepreneurship, experienced investor and deal maker with a demonstrated history of finding and fueling innovation to advance human healthcare. Skilled in Digital Health, Medical Devices, Biotechnology, Entrepreneurship, Venture Capital, and Strategic Transactions. Strong entrepreneurial spirit with a MBA from Columbia Business School.
Passionate supporter of innovation and entrepreneurship, experienced investor and deal maker with a demonstrated history of finding and fueling innovation to advance human healthcare. Skilled in Digital Health, Medical Devices, Biotechnology, Entrepreneurship, Venture Capital, and Strategic Transactions. Strong entrepreneurial spirit with a MBA from Columbia Business School.
Renee Ryan is recognized as an industry insider and leading investor, deal-maker, and innovator. She will present Cala Health at the 2021 Emerging Medtech Summit.
Ryan has 25 years of building category-creating healthcare companies. She led the medical technology investments for Johnson & Johnson Innovation (JJDC) on the West Coast and Asia Pacific for 8 years. While at J&J, she made over 15 new investments, including the Series A for Cala Health. Previously, she was a healthcare investment banker at RW Baird, Jefferies and Goldman Sachs
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy